Condition
Short-term Insomnia
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Acupuncture
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
Phase 2 (2)
Trial Status
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06278077Phase 2Completed
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
NCT06212934Not ApplicableUnknownPrimary
"Chou's Tiaoshen" Acupoints for Short-term Insomnia.
NCT02671760Phase 2CompletedPrimary
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
Showing all 3 trials
Research Network
Common Treatments
- Acupuncture1
- Comparator1
- Estazolam1
- Neurexan1
- Sm11
Active Sponsors
- Biologische Heilmittel Heel GmbH1
- Beijing Hospital of Traditional Chinese Medicine1
- Clinilabs, Inc.1
- Sequential Medicine Ltd1
Top Investigators
Beijing Hospital of Traditional Chinese Medicine
Clinilabs, Inc.
Sequential Medicine Ltd
Related Conditions
- Stress Reaction1
- Insomnia1